Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 4 | Rare Historical Photos

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

The Conversation

Medtronic wants every business unit to have a plan for AI

Companies and organizations from Medtronic to the state of California are deploying AI to improve workflows and outcomes.

Fortune

One company paying out $7.7 million in employee tuition benefits says one change to their program made a huge difference

Medical tech business Medtronic eliminated $7.7 million in student debt, removing its degree requirements, while sending hundreds of employees back to school.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

1 Dividend Aristocrat to Buy at a Discount This September

This dividend-paying stock is trading at an attractive valuation, making it a solid pick for investors seeking value and steady income.

Barchart

How Is Medtronic's Stock Performance Compared to Other Medical Devices Stocks?

Medtronic has lagged behind other medical device stocks over the past months, yet Wall Street remains moderately bullish on the stock’s prospects.

Barchart

Is Boston Scientific Stock Outperforming the Nasdaq?

Boston Scientific has outperformed the Nasdaq Composite over the past year, and analysts remain bullish on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

3 Robotics Stocks to Watch for the Automation Revolution

The robotics industry’s long-term growth is fueled by rapid technological advancements and automation across several sectors. Thus, it could be wise to keep an eye on fundamentally solid robotics stocks Stryker (SYK), Honeywell International (HON), and Medtronic (MDT) to capitalize on the automation revolution. Keep reading….

StockNews.com

3 MedTech Stocks Innovating Healthcare

MedTech’s bright future is fueled by rapid tech advancements and increasing demand for medical devices, implants, and precision treatments, driven by an aging population and rising global disease rates. Given this backdrop, adding strong MedTech stocks like Boston Scientific (BSX), Stryker (SYK), and Abbott (ABT) to one’s portfolio could be…

StockNews.com

Stock Index Futures Tread Water as Investors Brace for Fed Minutes and Powell’s Speech

September S&P 500 E-Mini futures (ESU24) are up +0.01%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.09% this morning as market participants geared up for the release of the minutes of the Federal Reserve’s latest meeting and comments from Fed Chair Jerome Powell later in the week.

Barchart

Stock Index Futures Tick Higher on Fed Rate Cut Bets, Powell Speech Awaited

September S&P 500 E-Mini futures (ESU24) are up +0.10%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.17% this morning after a strong session on Wall Street amid expectations that the Federal Reserve will soon signal readiness to begin cutting interest rates.

Barchart

Harvard expert and former Medtronic CEO describes fellow Minnesotan Tim Walz as ‘very moderate’

Bill George assesses Walz's leadership ability.

Fortune

Nervous About the Market? 3 Defensive Stock Picks to Consider This August

Explore three defensive stock picks from the consumer staples, healthcare, and utilities sectors that offer stability amid market uncertainty in August.

Barchart

Do Wall Street Analysts Like Medtronic Stock?

Medtronic has underperformed the broader market over the past year, but Wall Street analysts are moderately optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Medtronic Earnings Preview: What to Expect

Medtronic is expected to release its fiscal first-quarter earnings next month, and analysts expect its earnings to remain unchanged year over year.

Fortune

Industry leaders say companies are adopting AI, but cost and reliability remain key challenges

Leaders from Adobe, Wayfair, Wipro, Freshworks and Medtronic, who gathered at Fortune‘s Brainstorm Tech conference, shared first-hand experience and insights on where it makes sense to implement GenAI within the organization and where it doesn't.

Fortune

HP's next CFO makes the leap from Medtronic in latest example of top finance chiefs carving new paths

Karen Parkhill begins her role as finance chief at HP on Aug. 5.

TechRadar

Surgeons say they're losing hundreds of work hours due to inefficient tech

A lack of adequate technology solutions is forcing surgeons to use generic consumer tech, leading to huge inefficiencies.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Stryker Stock Underperforming the Dow

Stryker has recently underperformed the Dow Jones, but Wall Street analysts anticipate a moderate upside for the stock.

Barchart

Medtronic Stock: Is MDT Underperforming the Healthcare Sector?

Despite Medtronic consistently underperforming the broader healthcare sector, Wall Street analysts remain cautiously optimistic about the stock’s outlook.

Barchart

Is Intuitive Surgical Stock Outperforming the S&P 500?

Intuitive Surgical has recently outperformed the S&P 500, and Wall Street analysts are moderately optimistic about the stock’s prospects.

Fortune

CEOs can hurt their companies if they stay too long. When’s the right time to say goodbye?

Around year 10 of a leader's tenure, it's time to watch for these danger signs.

Barchart

Is This Dividend Aristocrat a Buy for Its 3% Yield?

Medtronic stock has underperformed so far in 2024. Is this future Dividend King worth buying as quarterly payouts continue to grow?

Barchart

Medtronic Stock Outlook: Is Wall Street Bullish or Bearish?

Medtronic has underperformed the broader market over the past year, but Wall Street analysts are still moderately bullish about the stock’s prospects.

Barchart

5 Standout Healthcare Dividend Stocks to Consider Now

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.